Originally Published MX September/October 2004

BUSINESS DRIVERS

St. Jude Medical (St. Paul, MN) has announced that its Daig division will be separated into two new divisions: cardiology and atrial fibrillation. Paul R. Buckman has been appointed president of the new cardiology division. Most recently, Buckman was chairman and CEO of ev3 LLC (Plymouth, MN), a medical device company focused on endovascular therapies. Jane J. Song has been appointed president of the new atrial fibrillation division. She has served as president of the company's cardiac surgery division since 2002, and was previously senior vice president of operations for St. Jude's cardiac rhythm management division. George J. Fazio, president of St. Jude Europe since 2001, will replace Song as president of the cardiac surgery division. Replacing Fazio will be Denis M. Gestin, who is currently vice president for northern Europe and Africa and previously managed the company's subsidiary in France. St. Jude also announced that David Adinolfi, who has served as president of the Daig division since 2001, has decided to retire.

Hall